The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab
Budai, B., Nagy, T., Láng, I., Hitre, E.Volume:
16
Language:
english
Journal:
Angiogenesis
DOI:
10.1007/s10456-012-9303-z
Date:
January, 2013
File:
PDF, 325 KB
english, 2013